| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Personalis Inc (NASDAQ: PSNL)
PSNL Technical Analysis
5
| As on 9th Jun 2023 PSNL STOCK Price closed @ 2.19 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 6.09 & Strong Sell for SHORT-TERM with Stoploss of 11.58 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PSNLSTOCK Price
| Open | 2.13 | Change | Price | % |
| High | 2.24 | 1 Day | 0.06 | 2.82 |
| Low | 2.11 | 1 Week | 0.39 | 21.67 |
| Close | 2.19 | 1 Month | -0.09 | -3.95 |
| Volume | 175200 | 1 Year | -12.48 | -85.07 |
| 52 Week High 14.82 | 52 Week Low 1.78 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| PSNL Daily Charts |
PSNL Intraday Charts |
Whats New @ Bazaartrend |
PSNL Free Analysis |
|
|
PSNL Important Levels Intraday
| RESISTANCE | 2.44 |
| RESISTANCE | 2.36 |
| RESISTANCE | 2.31 |
| RESISTANCE | 2.26 |
| SUPPORT | 2.12 |
| SUPPORT | 2.07 |
| SUPPORT | 2.02 |
| SUPPORT | 1.94 |
PSNL Forecast May 2024
| 4th UP Forecast | 11.27 |
| 3rd UP Forecast | 8.36 |
| 2nd UP Forecast | 6.56 |
| 1st UP Forecast | 4.76 |
| 1st DOWN Forecast | -0.38 |
| 2nd DOWN Forecast | -2.18 |
| 3rd DOWN Forecast | -3.98 |
| 4th DOWN Forecast | -6.89 |
PSNL Weekly Forecast
| 4th UP Forecast | 4.96 |
| 3rd UP Forecast | 4.07 |
| 2nd UP Forecast | 3.52 |
| 1st UP Forecast | 2.97 |
| 1st DOWN Forecast | 1.41 |
| 2nd DOWN Forecast | 0.86 |
| 3rd DOWN Forecast | 0.31 |
| 4th DOWN Forecast | -0.58 |
PSNL Forecast2024
| 4th UP Forecast | 28.3 |
| 3rd UP Forecast | 19.93 |
| 2nd UP Forecast | 14.75 |
| 1st UP Forecast | 9.57 |
| 1st DOWN Forecast | -5.19 |
| 2nd DOWN Forecast | -10.37 |
| 3rd DOWN Forecast | -15.55 |
| 4th DOWN Forecast | -23.92 |
Personalis Inc ( NASDAQ USA Symbol : PSNL )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PSNL Business Profile
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes versus. It serves biopharmaceutical customers, universities and non-profits, diagnostics companies, and government entities. The company has partnership with Berry Genomics; Natera, Inc.; and MapKure, LLC. Personalis, Inc. was founded in 2011 and is headquartered in Menlo Park, California. Address: 1330 O?Brien Drive, Menlo Park, CA, United States, 94025
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service